Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Domingo, S.
Right arrow Articles by Gamazo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Domingo, S.
Right arrow Articles by Gamazo, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1995) 36, 647-656
© 1995 The British Society for Antimicrobial Chemotherapy


other

Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice

Silvia Domingoa, Idoya Gastearenab, Ana I. Vitasc, Ignacio Lopez-Goñic, Carmen Dios-Viéitezb, Ramón Diaza,c and Carlos Gamazoc,*

aDpto. de Microbiologia Clinica Universitaria de Navarra, 31080 Pamplona, Spain bDpto. de Farmaciay Tecnologia Farmacéutica 31080 Pamplona, Spain cDpto. de Microbiologia Universidad de Navarra 31080 Pamplona, Spain

returned 29 December 1994; accepted 25 May 1995


*Corresponding author. E-mail: cgamazo{at}mail2.cti.unav.es

The activities of a short therapeutic regimen with azithromycin and the classic treatment doxycycline with streptomycin were compared and evaluated in mice infected with Brucella melitensis. In a chronic model, starting therapy 31 days after challenge, azithromycin (10 days, 50 mg/kg/day) significantly reduced the infection (2.9 logs, day 48 post-infection). The effectiveness of doxycycline (21 days, 50mg/kg/12 hourly) was greater than azithromycin (4.1 logs of reduction, day 48 post-infection), and when doxycycline was administered for a period of 45 days, all the animals were bacteriologically cured from day 78. The combination with streptomycin (14 days, 10 mg/kg/day) did not improve the effect of any of the regimens. In an acute model infection, treatments with doxycycline or doxycycline-streptomycin, for a period of 3 days, starting 1 day after lethal challenge, were able to protect all the mice. In contrast, only 50% of the mice treated with azithromycin survived the challenge. In conclusion, although a short oral treatment with azithromycin was able to reduce the infection significantly, it was not able to cure the animals as effectively as the classic regimen with doxycycline administered for a longer period of time.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
G. P. Wormser and I. Schwartz
Antibiotic Treatment of Animals Infected with Borrelia burgdorferi
Clin. Microbiol. Rev., July 1, 2009; 22(3): 387 - 395.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. J. Grillo, M. J. De Miguel, P. M. Munoz, C. M. Marin, J. Ariza, and J. M. Blasco
Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice
J. Antimicrob. Chemother., September 1, 2006; 58(3): 622 - 626.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Akova, D. Gur, D. M. Livermore, T. Kocagoz, and H. E. Akalin
In Vitro Activities of Antibiotics Alone and in Combination against Brucella melitensis at Neutral and Acidic pHs
Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1298 - 1300.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.